Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Workman

Showing results (211-220 of 268) with videos related to

Pageof 27
Sort By:
Journal of the National Cancer Institute|March 6, 1996
Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9S A Fitzsimmons, P Workman, M Grever, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
DT-diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and human colon carcinomasM I Walton, M C Bibby, J A Double, et al.
British Journal of Cancer|September 1, 1984
Preclinical pharmacokinetics of benznidazoleP Workman, R A White, M I Walton, et al.
British Journal of Cancer|September 17, 2002
Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycinD Liu, O C Hutchinson, S Osman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
CB 1954 revisited. II. Toxicity and antitumour activityP Workman, J E Morgan, K Talbot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1991
The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic studyN M Bleehen, T S Maughan, P Workman, et al.
British Journal of Cancer|August 1, 1995
The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysisE O Aboagye, A D Lewis, A Johnson, et al.
British Journal of Cancer|September 1, 1992
Tumour concentrations of flavone acetic acid (FAA) in human melanoma: comparison with mouse dataT S Maughan, R Ward, I Dennis, et al.
Journal of Chromatography. B, Biomedical Applications|October 6, 1995
Development and validation of a solid-phase extraction and high-performance liquid chromatographic assay for a novel fluorinated 2-nitroimidazole hypoxia probe (SR-4554) in Balb/c mouse plasmaE O Aboagye, M A Graham, A D Lewis, et al.
Molecular Pharmacology|October 20, 2000
Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivoS Y Sharp, L R Kelland, M R Valenti, et al.
Pageof 27

Showing results (211-220 of 268) with videos related to

Sort By:
Pageof 27
Journal of the National Cancer Institute|March 6, 1996
Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9S A Fitzsimmons, P Workman, M Grever, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
DT-diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and human colon carcinomasM I Walton, M C Bibby, J A Double, et al.
British Journal of Cancer|September 1, 1984
Preclinical pharmacokinetics of benznidazoleP Workman, R A White, M I Walton, et al.
British Journal of Cancer|September 17, 2002
Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycinD Liu, O C Hutchinson, S Osman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
CB 1954 revisited. II. Toxicity and antitumour activityP Workman, J E Morgan, K Talbot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1991
The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic studyN M Bleehen, T S Maughan, P Workman, et al.
British Journal of Cancer|August 1, 1995
The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysisE O Aboagye, A D Lewis, A Johnson, et al.
British Journal of Cancer|September 1, 1992
Tumour concentrations of flavone acetic acid (FAA) in human melanoma: comparison with mouse dataT S Maughan, R Ward, I Dennis, et al.
Journal of Chromatography. B, Biomedical Applications|October 6, 1995
Development and validation of a solid-phase extraction and high-performance liquid chromatographic assay for a novel fluorinated 2-nitroimidazole hypoxia probe (SR-4554) in Balb/c mouse plasmaE O Aboagye, M A Graham, A D Lewis, et al.
Molecular Pharmacology|October 20, 2000
Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivoS Y Sharp, L R Kelland, M R Valenti, et al.
Pageof 27